Public Health: Sorry, Your Life-Saving Drug Is Beyond Our Budget
Azrul Mohd Khalib, CEO, Galen Centre for Health & Social Policy | Professor Dr Asrul Akmal Shafie, Professor of Pharmacoeconomics, Universiti Sains Malaysia
10-Apr-25 16:00

Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
If you’re a patient at a government hospital or clinic, you probably don’t think twice about the medications you’re prescribed, though you’re probably grateful for the free treatment. But how does the Ministry of Health decide what therapies to include in the national medicines formulary? And as more innovative and expensive therapies are developed, how do we balance cost with public need? We uncover the decision-making process with Prof Dr Asrul Akmal Shafie, Professor of Pharmacoeconomics from Universiti Sains Malaysia.
Image Credit: Shutterstock
Produced by: Tee Shiao Eek
Presented by: Tee Shiao Eek
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: wellness
Tags: the bigger picture, health and living, publichealth, value based healthcare, healthcare financing, pharmaceutical,